APO Research
Talk to an analyst

APO RESEARCH · REPORT

Apomorphine Hydrochloride

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.

Selected research

Industry Growth & Trends

Global Apomorphine Hydrochloride Industry Growth and Trends Forecast to 2032

31 December 202590 pages

Choose your research edition.

Industry ResearchApomorphine Hydrochloride Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Apomorphine Hydrochloride Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Apomorphine Hydrochloride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Apomorphine Hydrochloride Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Apomorphine Hydrochloride Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.

The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.

Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.

Read the full market overview

Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.

Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Report Scope

This report provides a structured, data-driven view of the global Apomorphine Hydrochloride market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Apomorphine Hydrochloride market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Apomorphine Hydrochloride market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Apomorphine Hydrochloride.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Apomorphine Hydrochloride market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Apomorphine Hydrochloride Market by Company

Supernus Pharmaceuticals

Britannia Pharmaceuticals STADA

Ever Pharma

Evolan Pharma AB (PharmSwed)

Tianjin Tianwei Pharmaceutical

Sunovion

Apomorphine Hydrochloride Segment by Type

Injection

Tablets

Thinfilm

Nasal Powder (Pipeline)

Apomorphine Hydrochloride Segment by Application

Parkinson Disease

Erectile Dysfunction

Apomorphine Hydrochloride Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apomorphine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Apomorphine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apomorphine Hydrochloride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Apomorphine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Tablets Table 3. Major Company of Thinfilm Table 4. Major Company of Nasal Powder (Pipeline) Table 5. Global Apomorphine Hydrochloride Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Apomorphine Hydrochloride Sales by Type (2021-2026) & (K Units) Table 7. Global Apomorphine Hydrochloride Sales Market Share in Volume by Type (2021-2026) Table 8. Global Apomorphine Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 9. Global Apomorphine Hydrochloride Sales Market Share in Value by Type (2021-2026) Table 10. Global Apomorphine Hydrochloride Price by Type (2021-2026) & (USD/Unit) Table 11. Global Apomorphine Hydrochloride Sales by Type (2027-2032) & (K Units) Table 12. Global Apomorphine Hydrochloride Sales Market Share in Volume by Type (2027-2032) Table 13. Global Apomorphine Hydrochloride Sales by Type (2027-2032) & (US$ Million) Table 14. Global Apomorphine Hydrochloride Sales Market Share in Value by Type (2027-2032) Table 15. Global Apomorphine Hydrochloride Price by Type (2027-2032) & (USD/Unit) Table 16. North America Apomorphine Hydrochloride Sales by Type (2021-2026) & (K Units) Table 17. North America Apomorphine Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Apomorphine Hydrochloride Sales by Type (2021-2026) & (K Units) Table 19. Europe Apomorphine Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Apomorphine Hydrochloride Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Apomorphine Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Apomorphine Hydrochloride Sales by Type (2021-2026) & (K Units) Table 23. Latin America Apomorphine Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Apomorphine Hydrochloride Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Apomorphine Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 26. Apomorphine Hydrochloride Industry Trends Table 27. Apomorphine Hydrochloride Industry Drivers Table 28. Apomorphine Hydrochloride Industry Opportunities and Challenges Table 29. Apomorphine Hydrochloride Industry Restraints Table 30. Global Apomorphine Hydrochloride Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Apomorphine Hydrochloride Revenue Market Share by Company (2021-2026) Table 32. Global Apomorphine Hydrochloride Sales by Company (2021-2026) & (K Units) Table 33. Global Apomorphine Hydrochloride Sales Share by Company (2021-2026) Table 34. Global Apomorphine Hydrochloride Market Price by Company (2021-2026) & (USD/Unit) Table 35. Global Apomorphine Hydrochloride Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Apomorphine Hydrochloride Major Company Production Sites and Headquarters Table 37. Global Apomorphine Hydrochloride Company, Product Type & Application Table 38. Global Apomorphine Hydrochloride Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Apomorphine Hydrochloride by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Apomorphine Hydrochloride Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Apomorphine Hydrochloride Sales by Region (2021-2026) & (K Units) Table 43. Global Apomorphine Hydrochloride Sales Market Share in Volume by Region (2021-2026) Table 44. Global Apomorphine Hydrochloride Sales by Region (2021-2026) & (US$ Million) Table 45. Global Apomorphine Hydrochloride Sales Market Share in Value by Region (2021-2026) Table 46. Global Apomorphine Hydrochloride Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 47. Global Apomorphine Hydrochloride Sales by Region (2027-2032) & (K Units) Table 48. Global Apomorphine Hydrochloride Sales Market Share in Volume by Region (2027-2032) Table 49. Global Apomorphine Hydrochloride Sales by Region (2027-2032) & (US$ Million) Table 50. Global Apomorphine Hydrochloride Sales Market Share in Value by Region (2027-2032) Table 51. Global Apomorphine Hydrochloride Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 52. Global Apomorphine Hydrochloride Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Apomorphine Hydrochloride Sales by Application (2021-2026) & (K Units) Table 54. Global Apomorphine Hydrochloride Sales Market Share in Volume by Application (2021-2026) Table 55. Global Apomorphine Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 56. Global Apomorphine Hydrochloride Sales Market Share in Value by Application (2021-2026) Table 57. Global Apomorphine Hydrochloride Price by Application (2021-2026) & (USD/Unit) Table 58. Global Apomorphine Hydrochloride Sales by Application (2027-2032) & (K Units) Table 59. Global Apomorphine Hydrochloride Sales Market Share in Volume by Application (2027-2032) Table 60. Global Apomorphine Hydrochloride Sales by Application (2027-2032) & (US$ Million) Table 61. Global Apomorphine Hydrochloride Sales Market Share in Value by Application (2027-2032) Table 62. Global Apomorphine Hydrochloride Price by Application (2027-2032) & (USD/Unit) Table 63. North America Apomorphine Hydrochloride Sales by Application (2021-2026) & (K Units) Table 64. North America Apomorphine Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Apomorphine Hydrochloride Sales by Application (2021-2026) & (K Units) Table 66. Europe Apomorphine Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Apomorphine Hydrochloride Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Apomorphine Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Apomorphine Hydrochloride Sales by Application (2021-2026) & (K Units) Table 70. Latin America Apomorphine Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Apomorphine Hydrochloride Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Apomorphine Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 73. Supernus Pharmaceuticals Company Information Table 74. Supernus Pharmaceuticals Business Overview Table 75. Supernus Pharmaceuticals Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolio Table 77. Supernus Pharmaceuticals Recent Development Table 78. Britannia Pharmaceuticals STADA Company Information Table 79. Britannia Pharmaceuticals STADA Business Overview Table 80. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolio Table 82. Britannia Pharmaceuticals STADA Recent Development Table 83. Ever Pharma Company Information Table 84. Ever Pharma Business Overview Table 85. Ever Pharma Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Ever Pharma Apomorphine Hydrochloride Product Portfolio Table 87. Ever Pharma Recent Development Table 88. Evolan Pharma AB (PharmSwed) Company Information Table 89. Evolan Pharma AB (PharmSwed) Business Overview Table 90. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolio Table 92. Evolan Pharma AB (PharmSwed) Recent Development Table 93. Tianjin Tianwei Pharmaceutical Company Information Table 94. Tianjin Tianwei Pharmaceutical Business Overview Table 95. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolio Table 97. Tianjin Tianwei Pharmaceutical Recent Development Table 98. Sunovion Company Information Table 99. Sunovion Business Overview Table 100. Sunovion Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Sunovion Apomorphine Hydrochloride Product Portfolio Table 102. Sunovion Recent Development Table 103. North America Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 104. North America Apomorphine Hydrochloride Sales by Country (2021-2026) & (K Units) Table 105. North America Apomorphine Hydrochloride Sales Market Share by Country (2021-2026) Table 106. North America Apomorphine Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 107. North America Apomorphine Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 108. North America Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Apomorphine Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Apomorphine Hydrochloride Market Share by Country (2021-2026) Table 111. North America Apomorphine Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Apomorphine Hydrochloride Market Share Forecast by Country (2027-2032) Table 113. Europe Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. Europe Apomorphine Hydrochloride Sales by Country (2021-2026) & (K Units) Table 115. Europe Apomorphine Hydrochloride Sales Market Share by Country (2021-2026) Table 116. Europe Apomorphine Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 117. Europe Apomorphine Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Apomorphine Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Apomorphine Hydrochloride Market Share by Country (2021-2026) Table 121. Europe Apomorphine Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Apomorphine Hydrochloride Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Apomorphine Hydrochloride Sales by Country (2021-2026) & (K Units) Table 125. Asia-Pacific Apomorphine Hydrochloride Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Apomorphine Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 127. Asia-Pacific Apomorphine Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Apomorphine Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Apomorphine Hydrochloride Market Share by Country (2021-2026) Table 131. Asia-Pacific Apomorphine Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Apomorphine Hydrochloride Market Share Forecast by Country (2027-2032) Table 133. Latin America Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Latin America Apomorphine Hydrochloride Sales by Country (2021-2026) & (K Units) Table 135. Latin America Apomorphine Hydrochloride Sales Market Share by Country (2021-2026) Table 136. Latin America Apomorphine Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 137. Latin America Apomorphine Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Apomorphine Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Apomorphine Hydrochloride Market Share by Country (2021-2026) Table 141. Latin America Apomorphine Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Apomorphine Hydrochloride Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Apomorphine Hydrochloride Sales by Country (2021-2026) & (K Units) Table 145. Middle East and Africa Apomorphine Hydrochloride Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Apomorphine Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 147. Middle East and Africa Apomorphine Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Apomorphine Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Apomorphine Hydrochloride Market Share by Country (2021-2026) Table 151. Middle East and Africa Apomorphine Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Apomorphine Hydrochloride Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Apomorphine Hydrochloride Distributors List Table 156. Apomorphine Hydrochloride Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Apomorphine Hydrochloride Image Figure 2. Global Apomorphine Hydrochloride Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Apomorphine Hydrochloride Market Size (2021-2032) & (US$ Million) Figure 4. Global Apomorphine Hydrochloride Sales (2021-2032) & (K Units) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tablets Image Figure 8. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 9. Thinfilm Image Figure 10. Global Thinfilm Sales YoY Growth (2021-2032) & (K Units) Figure 11. Nasal Powder (Pipeline) Image Figure 12. Global Nasal Powder (Pipeline) Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Apomorphine Hydrochloride Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Apomorphine Hydrochloride Market Share by Type 2025 VS 2032 Figure 15. North America Apomorphine Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 16. North America Apomorphine Hydrochloride Sales Market Share in Value by Type in 2025 Figure 17. Europe Apomorphine Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 18. Europe Apomorphine Hydrochloride Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Apomorphine Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Apomorphine Hydrochloride Sales Market Share in Value by Type in 2025 Figure 21. Latin America Apomorphine Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Apomorphine Hydrochloride Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Apomorphine Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Apomorphine Hydrochloride Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Apomorphine Hydrochloride Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Parkinson Disease Image Figure 28. Global Parkinson Disease Sales YoY Growth (2021-2032) & (K Units) Figure 29. Erectile Dysfunction Image Figure 30. Global Erectile Dysfunction Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Apomorphine Hydrochloride Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Apomorphine Hydrochloride Market Share by Application 2025 VS 2032 Figure 33. North America Apomorphine Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 34. North America Apomorphine Hydrochloride Sales Market Share in Value by Application in 2025 Figure 35. Europe Apomorphine Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 36. Europe Apomorphine Hydrochloride Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Apomorphine Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Apomorphine Hydrochloride Sales Market Share in Value by Application in 2025 Figure 39. Latin America Apomorphine Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Apomorphine Hydrochloride Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Apomorphine Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Apomorphine Hydrochloride Sales Market Share in Value by Application in 2025 Figure 43. North America Apomorphine Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Apomorphine Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Apomorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Apomorphine Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Apomorphine Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Apomorphine Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Apomorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Apomorphine Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Apomorphine Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Apomorphine Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Apomorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Apomorphine Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Apomorphine Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Apomorphine Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Apomorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Apomorphine Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Apomorphine Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Apomorphine Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Apomorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Apomorphine Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Apomorphine Hydrochloride Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Apomorphine Hydrochloride Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablets
  • Thinfilm
  • Nasal Powder (Pipeline)
Applications
  • Parkinson Disease
  • Erectile Dysfunction
Companies covered
  • Supernus Pharmaceuticals
  • Britannia Pharmaceuticals STADA
  • Ever Pharma
  • Evolan Pharma AB (PharmSwed)
  • Tianjin Tianwei Pharmaceutical
  • Sunovion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Apomorphine Hydrochloride Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Apomorphine Hydrochloride Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Apomorphine Hydrochloride Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Tablets
  8. 1.3.3 Thinfilm
  9. 1.3.4 Nasal Powder (Pipeline)
  10. 1.4 Global Apomorphine Hydrochloride Market Size by Type
  11. 1.4.1 Global Apomorphine Hydrochloride Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Apomorphine Hydrochloride Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Apomorphine Hydrochloride Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Apomorphine Hydrochloride Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Apomorphine Hydrochloride Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Apomorphine Hydrochloride Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Apomorphine Hydrochloride Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Apomorphine Hydrochloride Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Apomorphine Hydrochloride Industry Trends
  2. 2.2 Apomorphine Hydrochloride Industry Drivers
  3. 2.3 Apomorphine Hydrochloride Industry Opportunities and Challenges
  4. 2.4 Apomorphine Hydrochloride Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Apomorphine Hydrochloride Revenue (2021-2026)
  2. 3.2 Global Top Players by Apomorphine Hydrochloride Sales (2021-2026)
  3. 3.3 Global Top Players by Apomorphine Hydrochloride Price (2021-2026)
  4. 3.4 Global Apomorphine Hydrochloride Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Apomorphine Hydrochloride Major Company Production Sites & Headquarters
  6. 3.6 Global Apomorphine Hydrochloride Company, Product Type & Application
  7. 3.7 Global Apomorphine Hydrochloride Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Apomorphine Hydrochloride Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Apomorphine Hydrochloride Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Apomorphine Hydrochloride Tier 1, Tier 2, and Tier 3
4 Apomorphine Hydrochloride Regional Status and Outlook
  1. 4.1 Global Apomorphine Hydrochloride Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Apomorphine Hydrochloride Historic Market Size by Region
  3. 4.2.1 Global Apomorphine Hydrochloride Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Apomorphine Hydrochloride Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Apomorphine Hydrochloride Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Apomorphine Hydrochloride Forecasted Market Size by Region
  7. 4.3.1 Global Apomorphine Hydrochloride Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Apomorphine Hydrochloride Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Apomorphine Hydrochloride Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Apomorphine Hydrochloride by Application
  1. 5.1 Apomorphine Hydrochloride Market by Application
  2. 5.1.1 Parkinson Disease
  3. 5.1.2 Erectile Dysfunction
  4. 5.2 Global Apomorphine Hydrochloride Market Size by Application
  5. 5.2.1 Global Apomorphine Hydrochloride Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Apomorphine Hydrochloride Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Apomorphine Hydrochloride Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Apomorphine Hydrochloride Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Apomorphine Hydrochloride Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Apomorphine Hydrochloride Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Apomorphine Hydrochloride Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Apomorphine Hydrochloride Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Supernus Pharmaceuticals
  2. 6.1.1 Supernus Pharmaceuticals Company Information
  3. 6.1.2 Supernus Pharmaceuticals Business Overview
  4. 6.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolio
  6. 6.1.5 Supernus Pharmaceuticals Recent Developments
  7. 6.2 Britannia Pharmaceuticals STADA
  8. 6.2.1 Britannia Pharmaceuticals STADA Company Information
  9. 6.2.2 Britannia Pharmaceuticals STADA Business Overview
  10. 6.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolio
  12. 6.2.5 Britannia Pharmaceuticals STADA Recent Developments
  13. 6.3 Ever Pharma
  14. 6.3.1 Ever Pharma Company Information
  15. 6.3.2 Ever Pharma Business Overview
  16. 6.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ever Pharma Apomorphine Hydrochloride Product Portfolio
  18. 6.3.5 Ever Pharma Recent Developments
  19. 6.4 Evolan Pharma AB (PharmSwed)
  20. 6.4.1 Evolan Pharma AB (PharmSwed) Company Information
  21. 6.4.2 Evolan Pharma AB (PharmSwed) Business Overview
  22. 6.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolio
  24. 6.4.5 Evolan Pharma AB (PharmSwed) Recent Developments
  25. 6.5 Tianjin Tianwei Pharmaceutical
  26. 6.5.1 Tianjin Tianwei Pharmaceutical Company Information
  27. 6.5.2 Tianjin Tianwei Pharmaceutical Business Overview
  28. 6.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolio
  30. 6.5.5 Tianjin Tianwei Pharmaceutical Recent Developments
  31. 6.6 Sunovion
  32. 6.6.1 Sunovion Company Information
  33. 6.6.2 Sunovion Business Overview
  34. 6.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sunovion Apomorphine Hydrochloride Product Portfolio
  36. 6.6.5 Sunovion Recent Developments
7 North America by Country
  1. 7.1 North America Apomorphine Hydrochloride Sales by Country
  2. 7.1.1 North America Apomorphine Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Apomorphine Hydrochloride Sales by Country (2021-2026)
  4. 7.1.3 North America Apomorphine Hydrochloride Sales Forecast by Country (2027-2032)
  5. 7.2 North America Apomorphine Hydrochloride Market Size by Country
  6. 7.2.1 North America Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Apomorphine Hydrochloride Market Size by Country (2021-2026)
  8. 7.2.3 North America Apomorphine Hydrochloride Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Apomorphine Hydrochloride Sales by Country
  2. 8.1.1 Europe Apomorphine Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Apomorphine Hydrochloride Sales by Country (2021-2026)
  4. 8.1.3 Europe Apomorphine Hydrochloride Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Apomorphine Hydrochloride Market Size by Country
  6. 8.2.1 Europe Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Apomorphine Hydrochloride Market Size by Country (2021-2026)
  8. 8.2.3 Europe Apomorphine Hydrochloride Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Apomorphine Hydrochloride Sales by Country
  2. 9.1.1 Asia-Pacific Apomorphine Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Apomorphine Hydrochloride Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Apomorphine Hydrochloride Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Apomorphine Hydrochloride Market Size by Country
  6. 9.2.1 Asia-Pacific Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Apomorphine Hydrochloride Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Apomorphine Hydrochloride Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Apomorphine Hydrochloride Sales by Country
  2. 10.1.1 South America Apomorphine Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Apomorphine Hydrochloride Sales by Country (2021-2026)
  4. 10.1.3 South America Apomorphine Hydrochloride Sales Forecast by Country (2027-2032)
  5. 10.2 South America Apomorphine Hydrochloride Market Size by Country
  6. 10.2.1 South America Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Apomorphine Hydrochloride Market Size by Country (2021-2026)
  8. 10.2.3 South America Apomorphine Hydrochloride Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Apomorphine Hydrochloride Sales by Country
  2. 11.1.1 Middle East and Africa Apomorphine Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Apomorphine Hydrochloride Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Apomorphine Hydrochloride Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Apomorphine Hydrochloride Market Size by Country
  6. 11.2.1 Middle East and Africa Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Apomorphine Hydrochloride Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Apomorphine Hydrochloride Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Apomorphine Hydrochloride Value Chain Analysis
  2. 12.1.1 Apomorphine Hydrochloride Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Apomorphine Hydrochloride Production Mode & Process
  7. 12.2 Apomorphine Hydrochloride Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Apomorphine Hydrochloride Distributors
  10. 12.2.3 Apomorphine Hydrochloride Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst